Japan colorectal tumor prevention study: randomized controlled trial of curcumin
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Interventions: curucmin 360mg/day placebo Primary outcome(s): The occurrence of a colorectal tumor (adenoma or cancer) is selected as the primary endpoint. Study Design: Parallel Randomized
创建时间：
2016-04-15
